The FDA currently approves chloroquine phosphate and chloroquine sulfate for the treatment of malaria caused by susceptible strains of Plasmodium vivax, Plasmodium malariae, Plasmodium ovale, and Plasmodium falciparum (except in areas of high resistance). It’s crucial to remember that chloroquine resistance is a significant concern in many parts of the world.
Additionally, chloroquine phosphate is approved for the treatment of acute attacks of rheumatoid arthritis. This application is less common than its use in malaria treatment.
Prescribing information should always be consulted for complete details on dosage, contraindications, and potential side effects. These medications are prescription-only and require a doctor’s assessment before use. Self-medication is dangerous and strongly discouraged.
| Chloroquine Phosphate | Malaria, Rheumatoid Arthritis |
| Chloroquine Sulfate | Malaria |
Always consult your physician or other qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
